OpenAI and Moderna expand AI use in drug development

Moderna is expanding its work with OpenAI. Before adopting ChatGPT Enterprise, the company built an internal tool called mChat on OpenAI's API, and AI is now being applied to drug development.

• Moderna built internal tool mChat on OpenAI's API
• The company moved to ChatGPT Enterprise
• Partnership expands into drug development